Investment Q&A

Q: Your thoughts on these 4 new companies for my speculative portfolio, long term hold 5 years. Thank you!

Q: For a retired person that wants to preserve their capital, what do you think about
RBC series A mutual fund RBF 209?

Q: Hello, when one reads the company profiles of both HON and RTX, there are some similarities but it seems that RTX is more government dependent (government IT contractor, defense, intelligence). If you had to buy just one of these companies, which one would it be? Thanks, Gervais

Q: I have taken a position in LUN given the recent "weaknesses" and was wondering if you could comment on both LUN and LUG looking forward as growth plays?
Thank-you.
Calvin

Q: I’m wondering what you think of PNG ( Kraken Robotics). They recently announced some deals for their equipment with a few Countries, what kind of prospects do you see for them and would you see them as an acquisition target by a larger Defence company ?
Thanks

Q: I am planning to take some losses as offsets to capital gains from previous years. In some cases, I am considering replacements as well. Please advise of any concerns with, or suggest alternatives to, the following sale (purchase) plan.

Sell HWO, PSI & IPL (buy PPL and AQN - already own ENB, ALA & KEY)

Sell SU & CJ (buy CNQ and PXT - already own ARX). I also have a sizeable loss on VET, but consider that is presently so far below comparables, that I should wait for some recovery – or sell now and move on?

Sell HR.UN (buy another REIT, possibly TCN.UN and/or ERE.UN - already own IIP.UN & NWH.UN).

Sell CHR.

Thanks - Don

Q: We are retired, primarily income investors. We did hold relatively equal positions in SRU,un and CHP.un, but this has changed rather significantly. In view of the current uncertainty about retail marketing, what is your opinion about investments in these two companies. Would you comment on the sustainability of SRU's dividend? Thank you for all the great ideas and comments.
Jane

Q: hi guys
Will 5i put this stock in the growth portfolio, could you offer a little info. on this co. buy or wait
Bob

Q: Hi crew, I see many loan defaults in the near future, is your conviction of GSY the same? How so?

Thank you,
Kevin

Q: Can I have your opinion on this etf. Has done well since the March sell off, but long term not so much. Has many of your growth favorites. Was there a recent change in management or strategy to explain this uptick.
Thanks Peter

Q: Please take as many question credits
you need to fully answer this. I would like growth and reasonably safe stocks. I have losses in all of these; should I sell and take the loss? Hold as they are likely to recover in next 6--12 months? Thanks. Helen

Q: I have a small (30K)cash account that is currently divided into three, with equal amounts in cash, AQN and ENB. I am adding more money to the account and would like to either add another position or add to one of the two securities I already have. Please advise. I do not have to worry about diversity. I just want a good, fairly safe, dividend payer.

Q: Hi, in Aug. I received 21 shares of BEPC from holding BEP.UN and I noticed that the book value was 1270.08 and today it's 1253.99. I think I received it at around 60.67 and today it's higher. Why does the book value fluctuate, and how can I find out what price I got it for.
Thanks, Nick

Q: Back in July 2020, I purchased ABBV, in a non-registered account, to get exposure to the healthcare sector and to continue to diversify my portfolio outside Canada. Since that time, I am down 16% on ABBV. Knowing 5i recommends ABBV, would you suggest I purchase more ABBV (average down)? Perhaps it would make more sense to sell it, take the tax loss, and purchase another healthcare company based outside of Canada. If your recommendation is to sell, what other healthcare sector companies would you suggest?

Q: I am thinking of selling ENB for a tax loss (again) and repurchasing it after 30 days. Your advice previously was to use PPL as a proxy. Would you still suggest the same strategy?

Appreciate your insight.

Paul F.

Q: PNG recently did a $10M "bought deal" financing at $.67. If it is a "bought deal" does that mean Canaccord are in essence buying $10M worth of newly issued shares at $.67 and they are getting a big discount (prior market was $.78-.80)? Will Canaccord be re-selling these shares to clients at a premium to themselves or just adding them to their own portfolios? Also, if Cannacord have already bought the shares why is the market reacting so negatively? Is it because of the dilution? Last but not least why such a big discount for Canaccord?

Q: I am looking for a silver play. Any suggestions? I'm open to higher risk options.

Q: I have read about Vanguard Index Funds and would like to pursue.
I have excess cash that I would like to invest long term in the broad US stock market. I DIY via Questrade - my current portfolio follows your Income Portfolio.
Which of the Vanguard funds would you suggest and could you provide the symbols for such? I'm assuming I could purchase these thru Questrade.
Thanks for your help.

Q: Hello -
According to TD Webroker, the PE for this ETF is about 23. I am trying to determine how this valuation compares to its historical past. Is this considered expensive for this ETF? I sure would be reluctant to purchase a stock at a PE of 23.

Thanks,
James

Q: I’m considering adding to my SHOP and KXS positions and initiating LSPD and CJT positions. I’m in no hurry and would like to purchase shares that have gone on sale(lol). I’d appreciate your commentary on the likelihood of the impact of two events in our immediate future and their impact on prices. My concerns involve: (1) the coming of winter and the impact on LSPD as restaurants shutter, potentially for good and (2) the impact of the US election if the result is dragged out for weeks in an ugly transition of power. I have no problem buying today, and I know you don’t recommend timing the market as there is always something to worry about, but it seems foolhardy to not consider the impact of events staring us in the face. Thanks for the guidance.